What Researchers Did
Researchers examined 86 patients with lung cancer to understand how their blood clotting system, specifically platelets, was affected and if hyperbaric oxygen therapy (HBOT) could help correct these changes.
What They Found
The study found that lung cancer patients showed increased platelet activity, including higher platelet counts and changes in cell membranes, making their blood more prone to slow clotting. These platelet indicators could help predict complications like infections and blood clots after surgery. Hyperbaric oxygen therapy (HBOT) was effective in correcting these alterations in the blood clotting system for lung cancer and its related suppurative complications.
What This Means for Canadian Patients
For Canadian patients with lung cancer, this older research suggests that HBOT might help manage blood clotting issues and reduce the risk of complications, especially after surgery. While not a standard treatment for lung cancer, it points to a potential role for HBOT in supporting recovery by improving blood health.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study was conducted in 1987 with a relatively small sample size of 86 patients, which may limit the generalizability of its findings.